Advances in Glucagon Detection Supporting Diabetes and Metabolic Disorder Research
This webinar is Part 4 of the Lumit™ Technology Webinar Series.
In this webinar, you will learn:
- About the importance of glucagon in blood glucose homeostasis and how its regulation goes awry during diabetes
- How better understanding of alpha cell signaling can inform new therapeutic strategies for treating diabetes
- How detection with Lumit™ speeds up analysis of these samples, allowing you to get results faster
Summary
Lumit™ Technology Webinar Series
Immunoassays are an essential tool for life science researchers, widely used for decades. Applying bioluminescent technology to this well-accepted assay format to create Lumit™ Immunoassays has made analyte detection faster and easier than ever before. This webinar series will introduce you to Lumit™ Immunoassay technology and highlight key research areas where bioluminescent immunoassays have supported research discoveries.
Part 4: Advances in Glucagon Detection Supporting Diabetes and Metabolic Disorder Research
In the fourth part of this series, Dr. Donna Leippe, Promega, will introduce Lumit™ Glucagon and Insulin Immunoassays and Dr. David Piston, Washington University St Louis, will describe how his lab uses islet perifusion as a key tool in their diabetes research. This model generates hundreds of samples per experiment and requires high-throughput immunoassays to measure insulin and glucagon secreted from the islets. See how Lumit™ Immunoassay technology speeds up the analysis of these samples, allowing you to get results faster.
Other Webinars in this Series:
Bioluminescent Analyte Detection with Lumit™ Immunoassays
Using Lumit™ Technology to Address Inflammasome-mediated Cytokine Release
Ask the Experts Forum: Implementing Lumit™ ImmunoassaysSpeakers
Donna Leippe, PhD
Senior Research Scientist
Promega
David Piston, PhD
Edward J. Mallinckrodt, Jr. Professor and Head of Cell Biology and Physiology
Washington University School of Medicine, St. Louis